MACSF

COMMUNIQUÉS West-GlobeNewswire

Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025
23/07/2025
ROCKVILLE, Md. and SUZHOU, China, July 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage Pharma ” or the “ Company ”), a global biopharmaceutical company dedicated [...]
Respiree Closes US$11.6M Series A Financing Round Led by We Venture Capital and ClavystBio
23/07/2025
HOUSTON and SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) -- Respiree , a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, announced the [...]
Quanta Announces Leadership Team Appointment and Highlights Clinical Program Progress
23/07/2025
– 25-year industry veteran Vanessa L. Jacoby appointed CBO and CFO, bringing financial and strategic leadership – – Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D- [...]
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
23/07/2025
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology [...]
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference
23/07/2025
SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have [...]
Humacyte Announces First Symvess™ Sale to Military Treatment Facility
23/07/2025
Sale follows recent Electronic Catalog (ECAT) listing approval by U.S. Defense Logistics Agency Symvess now available to U.S. Department of Defense and U.S. Department of Veterans Affairs facilities DURHAM, N.C., July [...]
electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025
23/07/2025
ROCKAWAY, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the second [...]
IMUNON Announces Reverse Stock Split
23/07/2025
LAWRENCEVILLE, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) , a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced a reverse stock split of its [...]
High Quality, Increased Member Satisfaction, Better Access to Care and Improved Outcomes Highlight Alignment Healthcare’s Impact in 2024
23/07/2025
New report outlines impact of company’s commitment to always putting seniors first ORANGE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today released its 2024 Impact Report [...]
Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
23/07/2025
THE WOODLANDS, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its second quarter 2025 financial results on Wednesday, August 6, 2025, prior [...]
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025
23/07/2025
ST. LOUIS, July 23, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial [...]
Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science
23/07/2025
Transforming a promising molecule into a clinically viable therapeutic platform Jupiter, Florida, July 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical- [...]
GH Research Announces Global Pivotal Program Plans and Further Development Updates
23/07/2025
Engagement with FDA on GH001 IND complete response ongoing The fully completed Open-Label Extension analysis confirms a 73% remission rate at 6 months with infrequent treatment visits and no psychotherapy Treatment was [...]
Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series
23/07/2025
SOUTH SAN FRANCISCO, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its [...]
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies
23/07/2025
CARE currently cooperates with 19 health insurance companies in Germany in the field of colorectal cancer screening BERKELEY, Calif. and MAINZ, Germany, July 23, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ [...]
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
23/07/2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, announced [...]
Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience
23/07/2025
Data confirms Company’s ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ( [...]
CORRECTING AND REPLACING - Safety Shot Announces Pricing of $10.6 Million Registered Direct Offering and Private Placement for Total Gross Proceeds of $16.3 Million.
23/07/2025
SCOTTSDALE, AZ, July 23, 2025 (GLOBE NEWSWIRE) -- In a release issued yesterday by Safety Shot, Inc. (Nasdaq: SHOT), please note that the pricing figures of the release have corrected. The corrected release reads as [...]
NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office
23/07/2025
Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the [...]

Pages